The low PDPN staining and high S100A4/PDPN ratios were positively associated with BRCA mutation in triple-negative BC but also demonstrated high patient survival rate and better prognosis outcome in both BC subtypes (i.e., ER+ and triple-negative with BRCA mutation BC). This evidence concerns the gene S100A4 and breast cancer.